CLB
Overvalued by 44.4% based on the discounted cash flow analysis.
Market cap | $569.29 Million |
---|---|
Enterprise Value | $580.52 Million |
Dividend Yield | $0.04 (0.33%) |
Earnings per Share | $0.67 |
Beta | 1.38 |
Outstanding Shares | 47,509,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 19.47 |
---|---|
PEG | 109.61 |
Price to Sales | 1.21 |
Price to Book Ratio | 2.43 |
Enterprise Value to Revenue | 1.12 |
Enterprise Value to EBIT | 10.93 |
Enterprise Value to Net Income | 19 |
Total Debt to Enterprise | 0.07 |
Debt to Equity | 0.16 |
No data
No data
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...